Bridget A. Ross - 07 May 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Director
Issuer ticker: LMAT
Reported as of: 07 May 2026
Net transaction value: -$560,366
SEC form: 4
Accepted by SEC: 11 May 2026, 17:10:42 UTC
Prior SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Bridget A. Ross filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 11 May 2026.

Key facts

This page summarizes Bridget A. Ross's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 17:10.

Change

Previous filing in this sequence was filed on 30 Mar 2026.
Current net transaction value: -$560,366.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698518 Primary reporting owner

Ross Bridget A

Relationship: Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,444
Change %: +87%
Price: $48.60^*
Shares after: 7,386
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,600
Change %: +22%
Price: $47.19^*
Shares after: 8,986
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Sale

Transaction value: $560,366
Shares: -5,044
Change %: -56%
Price: $111.10
Shares after: 3,942
Date: 07 May 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,444
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,444
Exercise price: $48.60
Footnotes: F3

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -1,600
Change %: -50%
Price: $0.000000^*
Shares after: 1,609
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,600
Exercise price: $47.19
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Footnote F2

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $111.00 to $111.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Footnote F3

This option is fully vested and exercisable.